Dongyang Pharmaceutical - B (01875.HK) announced the financial data for the nine months ending in September, with revenue of 0.809 billion RMB (the same below), an annual increase of 49.3%. Recorded a net profit of 35.4 million yuan, compared to a loss of 32.39 million yuan in the same period last year, turning losses into profits.
東曜藥業(01875.HK)首九個月純利3,540萬人民幣 虧轉盈
Tongyao Pharmaceutical (01875.HK) net profit for the first nine months was 35.4 million RMB, turning from a loss to a profit.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
How to view Tesla's performance in January 2025? Pay attention to these four key points.
It's earnings season for US stocks again. The performance of giant companies not only affects their own stock prices but also influences the overall trend of th
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha